INTRODUCTION
The high mortality of untreated Marfan syndrome (MFS) patients results almost exclusively from cardiovascular complications such as acute aortic dissection or rupture (1) . Mutation in fibrillin-1 leads to increased transforming growth factor beta (TGF-b) signaling activity, which may be related to an impairment of sequestration and extracellular control of TGF-b (2 -6). TGF-b is a potent inducer of SMAD2 phosphorylation and nuclear translocation, and alterations in both canonical and noncanonical TGF-b signaling are an important aspect of the pathogenesis of MFS (4,6 -8) . Missense mutations affecting either highly conserved cysteine residues or residues of the consensus sequence of calcium-binding epidermal growth factor (cbEGF) modules are common in MFS (9) . Presumably, such mutations affect the structure and conformation of the cbEGF module or cause alterations in interdomain flexibility (10, 11) , and in fact it has been shown repeatedly that FBN1 mutations can increase the susceptibility of fibrillin-1 to proteolysis (12) (13) (14) (15) (16) (17) (18) (19) .
Elastin is the dominant protein in the tunica media of the arterial and aortic wall, and elastin and fibrillin-1 each contain multiple copies of the GxxPG recognition sequence for the 67-kD elastin-binding protein (EBP) (20) . Fragments of elastin and fibrillin-1 can have a number of secondary effects such as induction of matrix metalloproteinase (MMP) expression and chemotaxis (20) (21) (22) . Many matrix proteins contain multiple GxxPG motifs. For instance, murine elastin contains 35 GxxPG sequences, human elastin (isoform a) contains 30 and both human and murine fibrillin-1 contain 3 GxxPG sequences (20) . We have previously shown that aortic extracts from the mgR/mgR mice as well as a GxxPG-containing fibrillin-1 fragment significantly increase macrophage chemotaxis compared with extracts from wild-type mice or buffer controls. The chemotactic response was significantly diminished by pretreatment of macrophages with lactose or with the elastin-derived peptide VGVAPG and by pretreatment of samples with the monoclonal antibody BA4, which is directed against the EBP recognition sequence GxxPG, suggesting that the chemotactic response was at least partially mediated by the EBP (22) . Recently, we have shown that the aortic extracts from human Marfan patients display a significantly higher chemotaxis inductive activity as well as a significantly higher BA4 reactivity compared with healthy controls (23) . Taken together, these observations suggest that GxxPGcontaining fragments might drive the progression of thoracic aortic aneurysm (TAA) in MFS. Marked fragmentation of elastin can be observed in pulmonary emphysema, and an imbalance between protease and antiprotease activity in the lung has been proposed as the major mechanism resulting in emphysema owing to an increase in the numbers of alveolar macrophages and neutrophils. Treatment with BA4 has been shown to eliminate both in vitro chemotactic activity and in vivo monocyte recruitment to the lung in a mouse model of pulmonary emphysema (24) . We, therefore, hypothesized that antagonism of GxxPG fragments by treatment with BA4 could represent an effective treatment of the aortic complications in MFS. In the current study, we show that the treatment of mgR/mgR Marfan mice with weekly intraperitoneal (i.p.) injections of BA4 significantly reduces several abnormalities characteristic for MFS in the aorta of the treated animals. Our findings suggest that GxxPG fragments are crucially involved in the progression of TAA in mgR/mgR mice.
RESULTS

Treatment with BA4 rescues elastin degeneration and decreases macrophage infiltration in mgR/mgR mice
Fibrillin-1 underexpressing mgR/mgR mice (25) were treated with weekly i.p. injections of the monoclonal antibody BA4 beginning at the third week of life and continuing over 8 weeks at a dose of 1 mg/kg, 5 mg/kg or 10 mg/kg. In all treatment groups, circulating BA4 reached peak concentration after 1 h and decreased gradually with time. The presence of BA4 in aortic and lung sections was confirmed in aortic and lung tissue by immunohistochemistry following i.p. injection of 1 mg/kg biotinylated BA4 (Fig. 1) . Following treatment, mice were sacrificed and compared with control IgG antibodytreated mgR/mgR and wild-type littermates. The elastic lamellae in the aorta of mgR/mgR mice appeared fragmented and disorganized in van Giesen staining when compared with the aorta of wild-type mice ( Fig. 2A and B) .
Treatment with BA4 at dosages as low as 1 mg/kg could already rescue elastin degeneration in mgR/mgR mice. However, no effects could be observed in the IgG-treated control group ( Fig. 2A) , demonstrating that the rescue of elastin degeneration is a result of targeting GxxPG-containing fragments by BA4. In addition, we also measured aortic medial thickness and found that the mgR/mgR mice treated with BA4 showed a significantly decreased aortic medial thickness compared with the IgG-treated mice (Fig. 2B) .
To characterize the effect of BA4 treatment on macrophage recruitment into the aortic wall, we performed immunostaining with F4/80, a widely used marker for mouse macrophages (26) . The mgR/mgR mouse has been shown to exhibit extensive macrophage infiltration at the adventitial border associated with aneurysmal dilatation (25) , and therefore, we quantified and compared only adventitial macrophages, although somewhat more variable media infiltration that was responsive to BA4 treatment was also observed (see Fig. 4 ). The mgR/mgR mice showed an over 6-fold increase in macrophage counts compared with the wild-type animals. Treatment with BA4 at a dosage as low as 1 mg/kg led to a reduction of macrophage counts in the aortic adventitia, whereas the control IgG Figure 1 . BA4 is present in serum, aortic and lung sections. (A) The serum concentration in all treatment groups reached peak concentration after 1 h and decreased gradually with time. The serum antibody concentration was still measurable in the 5 and 10 mg/kg treatment groups after 1 week, suggesting that weekly administration at these dosages is sufficient for maintenance of circulating levels of BA4 antibody. (B) Brown staining of biotinylated BA4 was found in both aortic and lung sections 24 h after i.p. injection of biotinylated BA4 (1 mg/kg). Unbiotinylated BA4 (1 mg/kg) was used as a control. Scale bar: 50 mm, inset scale bar: 15 mm. treatment did not. Even fewer macrophages were observed in the group treated with 10 mg/kg BA4 ( Fig. 2C and D) .
Treatment with BA4 inhibits upregulation of matrix metalloproteinase (MMP) expression in mgR/mgR mice Upregulation of the gelatinases MMP-2 and MMP-9 may be involved in the pathogenesis of aortic elastic fiber degeneration in MFS and their antagonism by oral doxycycline has been shown to be an effective treatment in mouse models of MFS (27, 28) . We, therefore, assessed the expression of MMP-2 and MMP-9 by western blotting of whole aorta protein. MMP-2 and MMP-9 expression was strongly increased in the aorta of mgR/mgR mice compared with the wild-type mice. Treatment with BA4 resulted in a statistically significant reduction of the MMP-2 and MMP-9 intensity compared with the IgG-treated mgR/mgR mice, whereby the inhibition of MMP-2 and MMP-9 upregulation was dosedependent (Fig. 3) .
Macrophages express and secrete various MMPs, including MMP-9 (29) . To examine whether the reduction of MMP-9 expression observed after BA4 treatment correlated with a reduced number of migrated macrophages, we performed double immunofluorescence analysis by using antibodies to both MMP-9 and the murine macrophage marker F4/80. Increased MMP-9 staining was demonstrated to be colocalized with F4/80+ macrophages present in both aortic media and adventitia of IgG-treated mgR/mgR mice (Fig. 4) . These results suggest that migrated macrophages are a major source of the upregulated MMP-9 expression observed in the aortic wall of mgR/mgR mice. Consistent with our results using immunohistochemical analysis and western blotting, BA4 treatment substantially reduced the numbers of migrated macrophages as well as the immunofluorescence signal of MMP-9.
Treatment with BA4 decreases upregulation of pSmad2 in mgR/mgR mice To determine whether BA4 could neutralize TGF-b signaling in the aorta of mgR/mgR mice, we monitored both pSmad2 and extracellular signal-regulated kinase (ERK) activities after the treatment. Immunostaining of pSmad2 in the aorta of mgR/mgR mice showed increased numbers of pSmad2-positive cells throughout the aortic media, whereas no pSmad2 immunopositivity was observed in healthy agematched controls (Fig. 5A ). Significantly fewer pSmad2-positive cells were observed in the aortic media of BA4-treated mice ( Fig. 5A and B) . Consistent with the immunohistochemical findings in aortic tissue, western blotting demonstrated that the BA4 at a dose of 10 mg/kg reduced pSmad2 expression to that of wild-type mice, and the reduction in pSmad2 expression was dose-dependent. In order to exclude a direct effect of the BA4 treatment on TGF-b signaling, we investigated the effects of BA4 treatment on cultured vascular smooth muscle cells (vSMCs) . No inhibition of TGF-b1-stimulated pSMAD2 activity was observed (data not shown), suggesting that the reduction in pSmad2 expression seen in the BA4-treated mgR/mgR mice was not a result of direct targeting of the TGF-b1 pathway by BA4. Recent studies have shown that pERK1/2, a mediator of noncanonical TGF-b signaling, is upregulated in Fbn1 C1039G/+ mice (6, 8) . In the current study, we also observed a comparable upregulation of pERK activity in mgR/mgR mice, but BA4 treatment did not affect pERK activity (Fig. 5C ). Constitutive pSmad2 activity has previously been identified in primary cultured aortic vSMCs from both human MFS patients and in mgR/mgR mice, and was suggested to reflect epigenetic reprogramming of aortic vSMCs (30, 31) . We, therefore, isolated aortic vSMCs from both BA4-treated (10 mg/kg) and untreated mgR/mgR mice for analysis. Immunofluorescence demonstrated increased nuclear pSmad2 expression in aortic vSMCs from mgR/mgR mice as well as a substantial reduction of the constitutive pSmad2 activation in aortic vSMCs from the BA4-treated mgR/mgR mice (Fig. 5D ). Western blotting of whole cell lysates demonstrated similar findings (Fig. 5E ).
Treatment with BA4 decreases upregulated TGFb1 and LTBP1 expression in mgR/mgR mice
Upregulated TGF-b1 expression colocalized with increased latent TGF-b-binding protein-1 (LTBP1) expression has been observed in the aortic media of MFS patients (7). We, therefore, investigated the expression of TGF-b1 and LTBP1 in the aortic wall of mgR/mgR mice as well as the effects of BA4 treatment on their expression and localization. Double immunofluorescence was performed on frozen aortic sections using anti-TGF-b1 in combination with anti-LTBP1 antibodies. A substantial increase in TGF-b1 staining was observed in the aortic media of IgG-treated mgR/mgR mice when compared with wild-type mice, and the increased TGF-b1 activity was associated with strong LTBP1 immunoreactivity (Fig. 6A ). BA4 treatment decreased both TGF-b1 and LTBP1 staining to the level seen in wild-type mice, and the effect was accompanied by normalization of the architecture of aortic wall of the mgR/mgR mice (Fig. 6A ). Consistent with these results, mRNA levels of Tgfb1 and Ltbp1 were also significantly higher in the aorta of mgR/mgR mice compared with age-matched wild-type mice (Fig. 6B ). Whole aorta protein was then measured by enzyme-linked immunosorbent assay (ELISA) for both total and active TGF-b1, demonstrating that both total and active TGF-b1 levels were significantly increased in whole aorta protein of mgR/mgR mice compared with the wild-type mice. The total and active TGF-b1 concentration was reduced to that of wild-type after BA4 treatment (Fig. 6C ).
Treatment with BA4 prevents the development of pulmonary emphysema in mgR/mgR mice Pulmonary emphysema associated with increased TGF-b activity has been previously shown in mgR/mgR mice (2) . Given the successful rescue of the aortic phenotype in mgR/ mgR mice, we also investigated whether BA4 treatment has a positive effect on the pulmonary manifestations of MFS.
Both morphometric assessment of airspace caliber by the mean linear intercept (MLI) and pSmad2 immunostaining confirmed the increase in airspace caliber and pSmad2 activity in the IgG-treated mgR/mgR mice ( Fig. 7A-C) . BA4 (10 mg/kg) reduced the value of MLI to that of wild-type mice (Fig. 7B) . Correspondingly, a substantial reduction of pSmad2 activity was observed in the BA4-treated group compared with the IgG-treated group (Fig. 7C) .
DISCUSSION
A number of extracellular matrix (ECM) proteins are known to have multiple biologically active binding motifs that remain masked in the intact ECM. However, once ECM is disrupted or injured, these motifs are exposed and can trigger a variety of transduction pathways, resulting in many cellular responses and leading to further destruction of elastin and other structural elements of the ECM (19) . In this work, we hypothesized that GxxPG fragments derived from elastin or fibrillin-1 could be driving the progression of aortic disease in the mgR/mgR mouse model of MFS and that antagonism of these fragments by the BA4 antibody, which reacts with bioactive GxxPG motifs (32), could alleviate manifestations of disease.
In our study, treatment with BA4 improved multiple manifestations of disease in a dose-dependent fashion, reducing or preventing the upregulation of MMP expression, pSmad2 expression, fragmentation of the elastic lamellae and macrophage infiltration into the aortic wall. Moreover, we confirmed by double immunofluorescence that decreased MMP-9 expression after BA4 treatment was associated with decreased macrophage migration into the aortic wall of mgR/mgR mice.
Macrophage infiltration into the aortic wall is an early event in the pathogenesis of TAA in mgR/mgR mice (25) , and macrophages are known to play an important role in regulating the turnover of ECM under both normal and pathological conditions via the secretion of proteases including MMPs, protease inhibitors and cytokines. Recent studies have observed macrophage infiltration in aortic specimens from patients with MFS (22, 33) . In this study, colocalization of MMP expression and macrophages in the aortic wall of mgR/mgR mice suggests that MMP-9 upregulation caused by macrophage infiltration could contribute to the fragmentation of the elastic lamellae of the aorta, and thus the inhibition of macrophage recruitment to the aorta by BA4 could contribute to the reduction of MMP expression in the BA4-treated mice. Although not investigated by this study, increased aortic MMP expression in the mgR/mgR mice may also come directly from the activation of the EBP downstream pathway in vSMCs triggered by GxxPG-containing fragments. In fact, stronger immunoreactivity for MMP-2 and -9 was found in the vSMCs at the border areas of cystic media necrosis than other regions from the aortic specimen of MFS patients (34) . Furthermore, elastin-derived peptides, which are highly enriched in GxxPG motifs, have been noted to stimulate the production of MMP-2 in cultured rat aortic vSMCs (35) .
In this study, double immunofluorescence and RT-PCR demonstrated elevated levels of both protein and messenger RNA (mRNA) of Tgfb1 and Ltbp1 in the aorta of mgR/mgR mice. Consistent with the findings in aortic specimens of MFS patients (7), there is also a strong colocalization between TGF-b1 and LTBP1 proteins in the aorta from mutant animals, suggesting that increased LTBP1 may facilitate the secretion and activation of TGF-b1. In addition, ELISA detected higher concentrations of both total and active TGF-b1 in the whole aorta protein of mutant versus wild-type mice. We suggest that the release of the active TGF-b1 from ECM together with autoactivation and regulation by TGF-b1 itself may be responsible for the abnormal TGF-b1 activity in the aorta of mgR/mgR mice. Indeed, it has been reported that TGF-b1 can positively stimulate its own expression and activation in the myocardial tissue from the transgenic mice overexpressing TGF-b1 (36) . It seems reasonable that the prevention of increased TGF-b1 activity by treatment with BA4 is a result of the preservation of elastin integrity, which maintains the ability of the matrix to control active TGF-b1. Indeed, microfibril proteolysis is thought to be a common mechanism for the release of active TGF-b1 from the ECM in heritable and acquired fibrillinopathies (37) . Furthermore, the impact of BA4 treatment on decreasing MMP expression could be also a result of improved sequestration of TGF-b1, since TGF-b1 can upregulate MMP-2 and MMP-9 production under certain conditions (38) . It was very recently shown that treatment with the angiotensin II type 1 receptor (AT1) inhibitor losartan attenuates aortic aneurysm development in the Fbn1 C1039G/+ mouse model of MFS by antagonism of ERK signaling (6). In our study, BA4 treatment showed no effects on ERK1/2 activity in spite of its efficient impact on pSmad2 and TGF-b1 activity. We note that the mgR/mgR mouse is a fibrillin-1 underexpressing mouse model, which presents a more severe phenotype compared with the Fbn1 C1039G/+ mouse. This difference in the results could reflect the differences in the underlying disease mechanism between these two mouse models, or different effects of the different treatment regimens on the cellular pathways involved in the pathogenesis of MFS. Another important finding of this study is that BA4 treatment decreased the constitutive pSmad2 activation in cultured aortic vSMCs from mgR/mgR mice. An overexpression of pSMAD2 in human aortic aneurysm vSMCs is associated with modifications of the histone H3 marker pattern in the vicinity of the 1a transcription start site on the SMAD2 promoter (31) . We infer that BA4 treatment may decrease pSmad2 expression by preventing the epigenetic reprogramming of aortic vSMCs in the initial phase of the disease, but the exact molecular mechanism requires further investigation.
It has been reported that antagonism of elastin degradation product-induced signaling by BA4 abrogated macrophage accumulation and airspace enlargement in a murine model of pulmonary emphysema (24) . In the current study, we have shown that BA4 treatment also prevented the development of pulmonary emphysema in mgR/mgR mice. It is of note to mention that the effect of BA4 is associated with decreased pSmad2 activity in lung alveolar septation. Based on these results, we suggest that GxxPG-containing fragments are a critical contributor to the development of pulmonary emphysema in homozygous mgR mice.
Our results support the notion that the parameters of cellular metabolism such as MMP expression and TGF-b signaling are intertwined with the state of the ECM. Since FBN1 mutations can make fibrillin-1 susceptible to proteolysis (19), we speculate that the production of low levels of proteolytic breakdown products could be an early event in the pathogenesis of aortic disease in MFS in the mgR/mgR model by inducing pathogenic events such as MMP upregulation and macrophage infiltration, and in turn, initiate a vicious cycle by promoting increased MMP expression and macrophage infiltration. Indeed, alterations in MMP activity and infiltration of inflammatory cells are visible in cardiovascular tissues of MFS patients (22, 33, 34, 39) . Doxycycline, which is known to inhibit MMP activity, has been shown to reduce upregulation of tissue expression of MMP-2 and MMP-9 and delay progression to thoracic aneurysm in mouse models of MFS (28, 40) and to have synergistic beneficial effects when given in combination with losartan, an AT1 receptor blocker that reduces TGF-b activity (41) . The results of our study, therefore, suggest an integrative model, in which proteolytic fragments of fibrillin or elastin and increased TGF-b signaling activity create a kind of vicious cycle in which matrix fragments induce deleterious effects including upregulation of MMP activity and macrophage infiltration, which, in turn, reinforces the pathological processes associated with matrix degradation and defects in TGF-b sequestration. Breaking of the vicious cycle could be achieved by abrogation of the interaction between GxxPG-containing fragments and EBP by BA4 (Fig. 8) .
In summary, our study emphasizes the important role of secondary cellular events caused by GxxPG-containing fragments and matrix-induced inflammatory activity in the pathogenesis of TAA in mgR/mgR mice. The current study is a proof-of-principle study, and further work will be required to determine the effects of BA4 treatment on survival and further parameters such as aortic dilatation. However, the results of the current study suggest that antagonism of the effects of GxxPG fragments may be a fruitful therapeutic strategy in MFS. It is tempting to speculate that a similar 
MATERIALS AND METHODS
Animals and study design
Heterozygous mgR fibrillin-1 underexpressing mice (25) were mated to generate wild-type, heterozygous and homozygous mgR mice. All animals were genotyped with the polymerase chain reaction as described previously (22) . The mice were given an i.p. application of BA4 antibody (Sigma-Aldrich) diluted in phosphate-buffered saline (PBS) at a dosage of 1 mg/kg, 5 mg/kg, or 10 mg/kg once a week. The treatment started at 3 weeks of age and continued for a total of 8 weeks. At the end of treatment, mice were sacrificed and aortic root, ascending aorta and arch were collected and either flash frozen in liquid nitrogen and stored at 2808C or treated in 1× PBS with 4% paraformaldehyde (PFA) overnight at 48C for preparing sections. Preparation of the aorta for double immunofluorescence staining was performed as described in the following section.
Mice were maintained under pathogen-free conditions, and the animal study was reviewed and approved by the Landesamt für Gesundheit und Soziales in Berlin (LaGeSo, Reg 0137/07).
Western blot of whole aorta protein
Whole aorta tissue (n ¼ 5 or 6 per group) was ground in 200 ml lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1% TritonX-100, 1 mM EDTA) with protease and phosphatase inhibitors (Roche Applied Science, Mannheim, Germany) and homogenized in a homogenizer. Samples were then mixed thoroughly by vortexing four times for 20 s and cooling on ice for 10-15 min. The samples were subsequently centrifuged at 10 000g at 48C for 15 min. The supernatant was then transferred to a fresh tube and stored at 2208C. Protein concentration was determined using the BCA assay kit (Pierce) and equal amounts (15 mg) were resolved by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis before transfer onto polyvinylidene fluoride membranes (Millipore). Immunodetection was performed by incubating at 48C with antibodies against MMP-2 (Abcam), MMP-9 (Abcam), pSMAD2 (Cell Signaling Technology), pERK1/2 (Cell Signaling Technology), ERK1/2 (Cell Signaling Technology) and b-actin (Abcam) as a loading control, followed by subsequent incubation with an appropriate horseradish peroxidase-conjugated secondary antibody. Protein expression was quantified using the ImageJ program.
Histology and Immunohistochemistry
The freshly prepared specimens of mouse ascending aorta and aortic arch were fixed in 1× PBS with 4% PFA overnight at 48C. Lungs were inflated to a pressure of 25 cm water with 4% PFA for about 10 min. Tissues were embedded in paraffin. The solidified paraffin-embedded tissues were then stored at 48C. These blocks were then sectioned into 5 mm microsections and used for further histological analysis after drying for at least one night. To visualize the elastic fibers of the aorta, the sections were stained with modified Verhoeff-van Giesen's stain. The free ends of elastic lamellae per millimeter aorta length and aortic medial thickness at 10-15 representative locations were counted and averaged by two independent observers. Five micrometer lung tissue sections were stained with hematoxylin and eosin. Immunohistochemical examinations were carried out using the ABC streptavidin -biotin method with the Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's protocol. Briefly, after deparaffinization and rehydration, endogenous peroxidase activity was quenched by a 5 min incubation in 3% H 2 O 2 . After trypsin-mediated antigen retrieval, the tissue sections were pre-incubated in prediluted blocking horse serum for 10 min to block nonspecific binding. Binding of primary rabbit anti-pSMAD2 (1:150, Cell Signaling Technology) or rat anti-F4/80 antibody (1:150, Abcam) was carried out overnight at 48C. The sections were then washed and subsequently incubated with a biotinylated panspecific universal secondary antibody for 10 min. After washing, a streptavidin peroxidase complex was added for 5 min. Antigen detection was performed by a 3 min incubation with 0.1% diaminobenzidine tetrahydrochloride and 0.01% hydrogen peroxide. The sections were then counterstained with hematoxylin, mounted in Entellan (Merck) and analyzed on a Leica MZ 12.5 stereomicroscope (Leica) coupled to the AxioCam HRc camera and the AxioVision 4.2 image analysis software. Infiltrated macrophage numbers were calculated in 10-15 random 200x fields by two independent observers.
Double Immunofluorescence
Mice were deeply anesthetized with isoflurane and transcardially perfused with 100 ml of 4% (w/v) PFA in PBS, pH 7.4. Then, tissue was post-fixed in the same fixatives for Figure 8 . Integrative model for effects of the monoclonal antibody BA4 (mAb BA4) in the aortic wall of mgR/mgR mice. Proteolytic fragments of matrix proteins including primarily elastin and fibrillin induce secondary deleterious effects including macrophage infiltration with increased MMP activity, which in turn leads to the production of more proteolytic fragments in a vicious cycle. FBN1 mutations increase the susceptibility of fibrillin-1 to proteolysis, and thus low levels of proteolytic degradation products of fibrillin-1 could be an early contributing factor to the development of disease. Fragmentation of elastin, which is present in greater quantities than fibrillin-1 and which has more GxxPG motifs, is likely to be an important additional factor in disease progression. By neutralizing GxxPG-containing fragments before they can elicit increased EBP signaling, BA4 may interrupt a GxxPG-driven vicious cycle. Solid lines correspond to direct activation, and dashed lines denote possible activation mediated by EBP. T-shaped solid and dashed lines represent direct and indirect inhibition. EBP, elastin-binding protein; ECM, extracellular matrix.
90 min, cryoprotected overnight in PBS containing 10% sucrose and cut into 8 mm sections. Mouse aorta-mounted tissue sections were incubated with the following primary antibodies: (a) rabbit polyclonal MMP-9 antibody (1:500, Abcam) in combination with rat monoclonal macrophage marker F4/80 antibody (1:500, Abcam) and (b) goat polyclonal LTBP1 antibody (1:500, Santa Cruz) in combination with rabbit polyclonal TGF-b1 (1:500, Santa Cruz). The tissue sections were washed with PBS and then incubated with the appropriate secondary antibodies: Alexa Fluor 594-conjugated donkey anti-rabbit antibody alone or in combination with Alexa Fluor 488 donkey anti-rat or anti-goat antibody (1:500). Finally, the nuclei were stained bright blue with 4 ′ ,6-diamidino-2-phenylindole (DAPI) (0.1 mg/ml in PBS) (Sigma) and then the tissue sections were mounted on vectashield (Vector Laboratories) and viewed under a Zeiss LSM 510 laser scanning microscope (Carl Zeiss, Göttingen, Germany). To demonstrate specificity of staining, the following controls were included: (i) omission of either the first or second primary antibody and (ii) either the first or second secondary antibody.
ELISA for measuring circulating BA4 antibody
Maxisorb 96-well microtiter plates (Nunc) were coated with 50 ml of an elastin peptide (0.5 mg/ml, CB573, Elastin Products Company) in PBS, pH 7.4 and incubated overnight at 48C. The wells were blocked with 100 ml of 0.5% bovine serum albumin (BSA) in PBS containing 0.05% Tween 20 (PBST). A standard curve was generated by a serially diluted BA4 antibody in PBS. The standard curves were fitted using a four-parameter logistic model. Mouse serum diluted 1:100 in PBS then added to each well in the elastin peptide-coated plate and incubated for 30 min at 378C, the plates were washed three times with PBST, followed by the addition 50 ml of secondary antibody (1:2000 anti-mouse IgG peroxidase conjugate). After 1 h incubation at 378C, the plates were washed three times, 50 ml of tetramethylbenzidine substrate solution (Thermo Fisher Scientific) was added and after 10 min incubation at RT the reaction was quenched by adding 50 ml of 1 M H 2 SO 4 to each well. The absorbance was measured at 450 nm using a microplate reader. The accuracy and precision of the quantitative range of the ELISA were determined by replicate analyses.
Detection of biotinylated BA4 in the lung and aortic section BA4 was biotinylated by using EZ-Link NHS-PEG4-Biotin and Biotinylation kit (Pierce) according to the manufacturer's protocol. The wildtype mice received an i.p. injection of biotinylated BA4 (1 mg/kg) and were sacrificed 24 h later. Then, aorta and lung sections were collected and embedded in paraffin. After deparaffinization and rehydration, endogenous peroxidase activity was quenched by a 5 min incubation in 3% H 2 O 2 , antigen retrieval was performed by immersing the tissue sections in Tris-EDTA buffer (10 mM Tris base, 1 mM EDTA Solution, 0.05% Tween 20, pH 9.0) and placing in a water bath set at 908C for 20 min. Biotinylated BA4 was then detected using the ABC streptavidin -biotin method with the Vectastain ABC kit (Vector Laboratories) according to the manufacturer's protocol.
Isolation of mouse aortic vSMCs
Ascending thoracic aorta specimens were removed and placed in PBS. For mouse aortic vSMC culture, the tunica adventitia was separated from the tunica media under aseptic conditions in the cell culture hood. Afterwards, pieces of tunica media were incubated in DMEM-containing collagenase type II (Worthington Biochemical Corporation, NJ; mg/ml) at 378C with 5% CO 2 for 1 h. Subsequently, the cell suspension was centrifuged at 1000 rpm for 5 min. The pellet was plated on a six-well plate and incubated in DMEM containing 10% FBS and antibiotics at 378C with 5% CO 2 . The cells from passage 3 -5 were used for the experiments shown in Figure. 4D. The vSMCs were identified by immunostaining with anti-a-SMA FITC-conjugated antibody (Abcam). Western blotting of the cell lysates was performed to measure pSmad2 levels using the pSMAD2 antibody from Cell Signaling Technology.
Immunofluorescence in vSMCs
The vSMCs were rinsed in PBS and fixed in 4% PFA in PBS for 10 min at 48C. After rinsing with PBS, the cells were permeabilized in 0.25% Triton X-100 in PBS for 5 min, followed by blocking the nonspecific binding sites with 3% BSA in PBS for 30 min. The cells were incubated with anti-pSMAD2 antibody (1:150, Cell Signaling Technology) overnight at 48C followed by a 30 min incubation of secondary Alexa Fluor 555 anti-rabbit IgG antibody (1:1000, Invitrogen). Nuclei were stained with DAPI for 1 min. Coverslips were mounted with Fluoromount.
Quantitative RT-PCR
Freshly dissected aortic tissue was flash-frozen in liquid nitrogen. The frozen samples were pulverized and total RNA was isolated using NucleoSpin RNA II (Macherey-Nagel, Duren, Germany) according to the manufacturer's protocol. RNA (500 ng) was reverse-transcribed using the Superscript First Strand synthesis kit (Invitrogen) in order to measure the mRNA level of Tgfb1, Ltbp1 and Fbn1 by quantitative RT-PCR on the Applied Biosystems 7900HT real-time PCR system using standard PCR conditions. Gapdh was used as an endogenous control. Primers are listed in Table 1 .
ELISA for total and active TGFb1
The concentration of total and active TGF-b1 was measured using a mouse TGF-b1 DuoSet (DY1679, R&D Systems) with a substrated reagent pack (DY999, R&D Systems) according to manufacturer's protocol. The total TGF-b1 level was measured by activating the aorta homogenates with 1N HCl (1:6) for 30 min and neutralized with an equal amount of 1.2 N NaOH. The results are reported as picograms of TGF-b1 per micrograms of total protein.
Morphology of lung tissue
MLI is a reflection of the mean air space diameter and was chosen to give information about alveolar abnormalities. The MLI measurements were performed using modified ImageJ software. Ten to fifteen random fields in hematoxylin and eosin-stained lung tissue sections were evaluated. Three mice in each group were analyzed.
Statistics
The results are reported as mean + standard error (s.e.m.). Pairwise comparisons were conducted using the MannWhitney U test. No adjustment was performed for multiple comparisons. P , 0.05 was considered as statistically significant.
Conflict of Interest statement. None declared. 
